Achieving More With Less: US FDA Offers ‘Road Map’ For AI In Rare Diseases

 
• By Sue Sutter
  
Road map
FDA officials described a "road map" for using AI in rare disease drug development. (Shutterstock)

More from Rare Diseases

More from United States